Stock Update (NYSE:ABT): Abbott to Present at Deutsche Bank Health Care Conference

[PR Newswire] – ABBOTT PARK, Ill., May 4, 2016 /PRNewswire/ — Abbott (NYSE: ABT) will present at the Deutsche Bank 41 st Annual Health Care Conference on Thursday, May 5, 2016. Tom Freyman, executive vice president, … Read more on this. Abbott Laboratories (ABT) , valued at $55.99B, began trading this morning at $38.35. Looking at today’s trading action, the company’s one day range from $38.00 to $38.46 with the price of the stock fluctuating between $36.00 to $51.74 over the last 52 weeks. Abbott Labs (ABT) shares are currently priced at 17.44x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -6.99x earnings multiple for the same period. The company pays shareholders $1.04 per share in dividend income per year, for a current yield of 2.67%. In a review of the consensus earnings estimate this quarter, 16 sell-side analysts are looking at $0.53 per share, which would be $0.01 better than the year-ago quarter and a $0.00 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $2.21 would be a $0.06 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $5.24 Billion. If reported, that would be a 1.35% increase over the year-ago quarter. More recently, Morgan Stanley downgraded ABT from Overweight to Equal-Weight (Jan 4, 2016). Previously, Goldman downgraded ABT from Buy to Neutral. When considering if the stock is under or overvalued, the average price target is $47.20, which is 23.08% above where the stock opened this morning. See more in (NYSE:ABT) Similar Articles: Stock Update: AbbVie Inc (NYSE:ABBV) – AbbVie to Present at the Bank of America Merrill Lynch 2016 Global Health Care Conference Stock Update: Abbott Laboratories (NYSE:ABT) – Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity Stock Update (NYSE:ABT): Abbott Introduces Ensure® Enlive®, Pairing the Latest in Science and Nutrition to Improve Health
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.